Microchip Technology(MCHP) - 2026 Q2 - Quarterly Results
2025-11-06 21:21
EXHIBIT 99.1 INVESTOR RELATIONS CONTACT: Sajid Daudi -- Head of Investor Relations..... (480) 792-7385 MICROCHIP TECHNOLOGY ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL YEAR 2026 CHANDLER, Arizona - November 6, 2025 - (NASDAQ: MCHP) - Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today reported results for the three months ended September 30, 2025. Steve Sanghi, Microchip's CEO and President commented that "Our second quarter re ...
Microchip Technology Incorporated(MCHPP) - 2026 Q2 - Quarterly Results
2025-11-06 21:21
EXHIBIT 99.1 INVESTOR RELATIONS CONTACT: Sajid Daudi -- Head of Investor Relations..... (480) 792-7385 MICROCHIP TECHNOLOGY ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL YEAR 2026 CHANDLER, Arizona - November 6, 2025 - (NASDAQ: MCHP) - Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today reported results for the three months ended September 30, 2025. Steve Sanghi, Microchip's CEO and President commented that "Our second quarter re ...
Genworth(GNW) - 2025 Q3 - Quarterly Report
2025-11-06 21:21
FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission file number 001-32195 GENWORTH FINANCIAL, INC. | | Trading | Name of each exchange | | --- | --- | --- | | Title of Each Class ...
Barings(BBDC) - 2025 Q3 - Quarterly Report
2025-11-06 21:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ Form 10-Q __________________________________________________________ (Mark One) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 814-00733 __ ...
Topgolf Callaway Brands (MODG) - 2025 Q3 - Quarterly Results
2025-11-06 21:20
HIGHLIGHTS CARLSBAD, CA /November 6, 2025/ Topgolf Callaway Brands Corp. (the "Company" or "Topgolf Callaway Brands," "we," "our," "us") (NYSE: MODG) announced its financial results for the third quarter ended September 30, 2025. "We are pleased with our third quarter results, with both revenue and Adjusted EBITDA exceeding our expectations," commented Chip Brewer, President and Chief Executive Officer of Topgolf Callaway Brands Corp. "These results were led by strong performance and market conditions in ou ...
Eastman Kodak(KODK) - 2025 Q3 - Quarterly Results
2025-11-06 21:20
Exhibit (99.1) Media Contact: Kurt Jaeckel, Kodak, +1 585-490-8646, kurt.jaeckel@kodak.com Investor Contact: Anthony Redding, Kodak, +1 585-724-4053, shareholderservices@kodak.com Company Achieved Significant Improvements in Gross Profit, Operational EBITDA and Cash Balance Pension Reversion Transaction Proceeding on Schedule with Expected Proceeds Increasing from $500 Million to $600 Million Previously Disclosed Going Concern Conditions Have Been Fully Resolved ROCHESTER, N.Y., November 6, 2025 – Eastman K ...
Alta Equipment (ALTG) - 2025 Q3 - Quarterly Report
2025-11-06 21:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-38864 ALTA EQUIPMENT GROUP INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 83-258378 ...
Pliant Therapeutics(PLRX) - 2025 Q3 - Quarterly Report
2025-11-06 21:20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39303 PLIANT THERAPEUTICS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 47-4272481 (State or other jurisdiction o ...
Mueller Water Products(MWA) - 2025 Q4 - Annual Results
2025-11-06 21:20
MUELLER WATER PRODUCTS REPORTS RECORD FOURTH QUARTER AND FULL YEAR 2025 RESULTS; INTRODUCES FISCAL 2026 GUIDANCE Increased Net Sales 9.4% in Quarter, 8.7% in Fiscal Year Earned Net Income per Diluted Share of $0.33 in Quarter, $1.22 in Fiscal Year Reported Adjusted Net Income per Diluted Share of $0.38 in Quarter, $1.31 in Fiscal Year Generated Adjusted EBITDA of $91.8 million in Quarter, $326.2 million in Fiscal Year "Fiscal 2025 was another year of record annual results including strong net sales growth a ...
Acacia(ACTG) - 2025 Q3 - Quarterly Report
2025-11-06 21:20
Table of Contents SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ______________ Commission file number: 001-37721 Acacia Research Corporation (Name of registrant as specified in its charter) Delaware 95-4405754 ( ...